Nektar Therapeutics
NASDAQ: NKTR
Healthcare
Biotechnology
Global Rank
#23296
Country Rank
#3407
Market Cap
118.49 M
Price
9.55
Change (%)
15.86%
Volume
501,755
Nektar Therapeutics's latest marketcap:
118.49 M
As of 06/12/2025, Nektar Therapeutics's market capitalization has reached $118.49 M. According to our data, Nektar Therapeutics is the 23296th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 118.49 M |
| Revenue (ttm) | 87.25 M |
| Net Income (ttm) | -133,041,000 |
| Shares Out | 12.41 M |
| EPS (ttm) | -9.52 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/08/2025 |
Market Cap Chart
Data Updated: 06/12/2025
Nektar Therapeutics's yearly market capitalization.
Nektar Therapeutics has seen its market value drop from $517.8 M to $118.49 M since 1998, representing a total decrease of 77.12% and an annual compound decline rate (CAGR) of 5.42%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/12/2025 | $118.49 M | -17.9% | 23296 |
| 12/31/2024 | $171.5 M | 59.09% | 19925 |
| 12/29/2023 | $107.8 M | -74.62% | 22531 |
| 12/30/2022 | $424.8 M | -82.96% | 13305 |
| 12/31/2021 | $2.49 B | -18.24% | 5366 |
| 12/31/2020 | $3.05 B | -19.69% | 4096 |
| 12/31/2019 | $3.8 B | -33.26% | 1013 |
| 12/31/2018 | $5.69 B | -39.5% | 718 |
| 12/29/2017 | $9.4 B | 401.47% | 587 |
| 12/30/2016 | $1.88 B | -16.61% | 1237 |
Company Profile
Nektar Therapeutics was founded in 1990 in United States.
The company went public on 05/03/1994
on the Nasdaq Stock Market.
With 61 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Nektar Therapeutics's (NKTR) current market cap?As of 06/12/2025, Nektar Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $118.49 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Nektar Therapeutics (NKTR) rank globally by market cap?Nektar Therapeutics global market capitalization ranking is approximately 23296 as of 06/12/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.